-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2022.
- Cyclacel Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2023 was -0.44 USD/shares, a 4.35% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2023 was -1.93 USD/shares, a 1.05% decline year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.9 USD/shares, a 9.09% increase from 2021.
- Cyclacel Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -2.09 USD/shares, a 38.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)